Top Stock Ideas Sent Daily — Join and Gain Your Edge
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Top Stock Ideas Sent Daily — Join and Gain Your Edge
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Esperion Therapeutics
ESPR
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.13
0.04
1.91%
At Close: -
$2.15
0.02
0.94%
After Hours: 7:46 PM EDT
15 minutes delayed
Get Report
Comment
Esperion Therapeutics (ESPR) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Esperion Therapeutics (NASDAQ:ESPR) Stock
Esperion Therapeutics Stock (NASDAQ: ESPR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, October 02, 2024
Esperion Therapeutics shares are trading high...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Esperio...
Benzinga Newsdesk
Esperion EU Partner Reports Final Real-World ...
Benzinga Newsdesk
Tuesday, September 03, 2024
Esperion Secures Additional Commercial And Me...
Benzinga Newsdesk
Tuesday, August 13, 2024
Needham Maintains Buy on Esperion Therapeutic...
Benzinga Newsdesk
Monday, August 12, 2024
HC Wainwright & Co. Reiterates Buy on Esperio...
Benzinga Newsdesk
Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Esperion Reiterates Its Full Year 2024 Operat...
Benzinga Newsdesk
Esperion Therapeutics Q2 2024 GAAP EPS $(0.33...
Benzinga Newsdesk
Friday, June 28, 2024
Needham Reiterates Buy on Esperion Therapeuti...
Benzinga Newsdesk
Esperion Therapeutics shares are trading lowe...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Esperio...
Benzinga Newsdesk
Esperion Therapeutics shares are trading high...
Benzinga Newsdesk
Esperion Says It Enters Into A Royalty Purcha...
Benzinga Newsdesk
Thursday, June 20, 2024
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Esperion Therapeutics shares are trading lowe...
Benzinga Newsdesk
Workday To Rally Over 52%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
B of A Securities Downgrades Esperion Therape...
Benzinga Newsdesk
Monday, June 10, 2024
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Friday, June 07, 2024
Argan Reports Strong Earnings, Joins Geron, Planet Labs PBC And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Wednesday, May 22, 2024
HC Wainwright & Co. Reiterates Buy on Esperio...
Benzinga Newsdesk
European Commission Approve NILEMDO And Its C...
Benzinga Newsdesk
Tuesday, May 21, 2024
HC Wainwright & Co. Reiterates Buy on Esperio...
Benzinga Newsdesk
Monday, May 20, 2024
Esperion Therapeutics/Otsuka Partnered Cholesterol Drug Shows Effective In Japan Study
Vandana Singh
Esperion, Otsuka Report Primary Endpoint Was ...
Benzinga Newsdesk
Tuesday, May 14, 2024
Esperion Receives Five Year Patent Extension ...
Benzinga Newsdesk
Wednesday, May 08, 2024
HC Wainwright & Co. Reiterates Buy on Esperio...
Benzinga Newsdesk
Tuesday, May 07, 2024
Needham Reiterates Buy on Esperion Therapeuti...
Benzinga Newsdesk
Esperion Therapeutics shares are trading high...
Benzinga Newsdesk
Heart Disease Drugmaker Esperion Therapeutics Reports Highest Revenue Yet, Stock Soars
Vandana Singh
CORRECTION: Esperion Therapeutics Sees FY24 O...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Esperion Therapeutics Q1 EPS $0.34 Beats $0.0...
Benzinga Newsdesk
Friday, April 12, 2024
Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
Thursday, April 11, 2024
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Wednesday, April 10, 2024
Needham Reiterates Buy on Esperion Therapeuti...
Benzinga Newsdesk
Monday, April 08, 2024
Esperion Therapeutics shares are trading lowe...
Benzinga Newsdesk
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Reported Sunday, Esperion Presents New Data F...
Benzinga Newsdesk
Wednesday, April 03, 2024
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Monday, March 25, 2024
Esperion Announces Data from CLEAR Outcomes S...
Benzinga Newsdesk
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
HC Wainwright & Co. Reiterates Buy on Esperio...
Benzinga Newsdesk
Why Is Heart Disease-Focused Esperion Therapeutics Stock Trading Higher On Monday?
Vandana Singh
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Market-Moving News for March 25th
Benzinga Newsdesk
Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Needham Reiterates Buy on Esperion Therapeuti...
Benzinga Newsdesk
Esperion shares are trading higher after the ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch